• Kyodo

  • SHARE

The health ministry has approved the use of the steroid drug dexamethasone for the treatment of novel coronavirus patients, following the approval of remdesivir in May, it came to light on Tuesday.

Dexamethasone has drawn international attention since it was reported in Britain last month that the drug reduced deaths among patients with severe cases of COVID-19, the respiratory disease caused by the virus.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)